Note: Ingredients listed on restricted chemical lists
EC/CAS
215-185-5/1310-73-2
Name of the chemical
sodium hydroxide
Concentration
<1% 5% <5% <2% <2%
General Information
Version
1.3
Revision date
2025-12-30
Product name
Lymphosep, Lymphocyte Separation Media
1.2.2. Uses advised against
The product, as such or as a component of a mixture, is not intended to be used by consumers (as defined by the REACH Regulation)
Emergency telephone
+44 (0) 1270 502894
Icons in SDS
Company Information
company name
VWR International GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
SDS@avantorsciences.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H319
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Hazard statements
H315 Causes skin irritation. H319 Causes serious eye irritation.
Precautionary statements
P264 Wash hands thoroughly after handling. P280 Wear protective gloves/protective clothing/eye protection/face protection. P302+P352 IF ON SKIN: Wash with plenty of water. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P321 Specific treatment (see FIRST AID on this label). P332+P313 If skin irritation occurs: Get medical advice/attention. P362+P364 Take off contaminated clothing and wash it before reuse.
2.3 Other hazards
The mixture does not contain a substance fulfilling the PBT criteria. The mixture does not contain a substance fulfilling the vPvB criteria. This product does not contain a substance identified as an endocrine disruptor.
2.1 Classification of the substance or mixture
2.1.1 Classification according to Regulation (EC) No 1272/2008 [CLP] Hazard classes and hazard categories Hazard statements Skin irritation, category 2 H315 Eye irritation, category 2 H319
